Introduction of MaxCell(TM)
BROOMFIELD, CO --- Unigen (TM) Pharmaceuticals, Inc. , a leading natural products research and development facility and proprietary ingredients supplier, announced that they were issued a key patent from the United States Patent and Trademark Office entitled "Multicomponent Biological Vehicle" invented by Qi Jia, vice president of scientific affairs at Unigen Pharmaceuticals.
This newly issued patent (6,395,311 B2) is for the invention titled MaxCell (TM), a novel biological vehicle that can be used for the delivery of a variety of biologically active agents. The components of MaxCell combine to enhance the performance of biologically active ingredients by magnifying intracellular communication and response to active nutrients and by providing renewal of the building blocks of life-cells.
“MaxCell can be used to deliver a variety of biologically active agents including, but not limited to nutrients and dietary supplements, such as essential minerals, vitamins, amino acids and derivatives, hormones and formulas,” stated Dr. Jia. "We have worked hard at establishing a dominant patent estate and are very pleased with the results so far."
The components of MaxCell not only function as a classical delivery system to target bioavailability but also emphasize the response from the targeted living cells through renewal, enhancement and protection functions.
Unigen is dedicated to the discovery of botanically derived therapeutic compounds that address consumer health needs and help improve the quality of human life. Unigen, and sister company Aloecorp, are subsidiaries of the Unigen Group of companies. Each company focuses on identifying and studying the unique ingredients of medicinal botanicals and then formulating proprietary raw materials for use in cosmeceutical, nutraceutical and pharmaceutical products.
For more information on Unigen(TM) Pharmaceuticals, Inc. contact www.unigenpharma.com or call 303.438.8666.
Unigen Pharmaceuticals, Inc.